Multifunctional Vector for Delivery of Genome Editing Plasmid Targeting β-Catenin to Remodulate Cancer Cell Properties.
暂无分享,去创建一个
Yan Peng | Xiao-Yan He | R. Zhuo | Si-Xue Cheng | Ren-Xi Zhuo | Si-Xue Cheng | Bo-Ya Liu | Bo-Ya Liu | Yan Peng | Xiao-Yan He
[1] Xuenong Zhang,et al. Nucleolin-Targeting AS1411-Aptamer-Modified Graft Polymeric Micelle with Dual pH/Redox Sensitivity Designed To Enhance Tumor Therapy through the Codelivery of Doxorubicin/TLR4 siRNA and Suppression of Invasion. , 2018, Molecular pharmaceutics.
[2] John O Trent,et al. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. , 2009, Experimental and molecular pathology.
[3] G. Rettig,et al. Knockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivo , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[4] K. Kalland,et al. Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer. , 2018, Nature chemical biology.
[5] Luigi Naldini,et al. Gene therapy returns to centre stage , 2015, Nature.
[6] A. Zimmer,et al. Protamine-oligonucleotide-nanoparticles: Recent advances in drug delivery and drug targeting. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[7] Zhangyong Hong,et al. Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles , 2017, Advanced functional materials.
[8] J. Hwang,et al. Cell-Penetrating Peptide-Patchy Deformable Polymeric Nanovehicles with Enhanced Cellular Uptake and Transdermal Delivery. , 2018, Biomacromolecules.
[9] Fajr A. Aleisa,et al. Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework. , 2018, Journal of the American Chemical Society.
[10] Gang Bao,et al. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery. , 2017, Chemical reviews.
[11] Dan Zhang,et al. The role of β-catenin in the initiation and metastasis of TA2 mice spontaneous breast cancer , 2017, Journal of Cancer.
[12] T. Aminabhavi,et al. Targeted delivery of small interfering RNA to colon cancer cells using chitosan and PEGylated chitosan nanoparticles. , 2016, Carbohydrate polymers.
[13] M. Stratton,et al. The cancer genome , 2009, Nature.
[14] Chao Wang,et al. Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing. , 2015, Angewandte Chemie.
[15] Zhen Gu,et al. Macrophage-Specific in Vivo Gene Editing Using Cationic Lipid-Assisted Polymeric Nanoparticles. , 2018, ACS nano.
[16] Yafeng Song,et al. Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway , 2017, Oncotarget.
[17] Jennifer A. Doudna,et al. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy , 2017, Nature.
[18] Christian Veltkamp,et al. Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice , 2016, Nature Communications.
[19] F. Beltram,et al. A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[20] T. Ohtsuki,et al. Enhanced intracellular peptide delivery by multivalent cell-penetrating peptide with bioreducible linkage. , 2017, Bioorganic & medicinal chemistry letters.
[21] R. Zhuo,et al. Functional polymer/inorganic hybrid nanoparticles for macrophage targeting delivery of oligodeoxynucleotides in cancer immunotherapy , 2017 .
[22] Ying Li,et al. CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation , 2015, Science Advances.
[23] Hao Zhu,et al. Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA. , 2017, Angewandte Chemie.
[24] T. Gajewski,et al. Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity , 2015, Nature.
[25] Wei Wang,et al. NOR1 Suppresses Cancer Stem‐Like Cells Properties of Tumor Cells via the Inhibition of the AKT‐GSK‐3β‐Wnt/β‐catenin‐ALDH1A1 Signal Circuit , 2017, Journal of cellular physiology.
[26] Hans Clevers,et al. Genome-wide CRISPR screens reveal a Wnt–FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors , 2016, Nature Medicine.
[27] Soyoung Lee,et al. Senescence-associated reprogramming promotes cancer stemness , 2017, Nature.
[28] S. Ramakrishna,et al. RGD/TAT-functionalized chitosan-graft-PEI-PEG gene nanovector for sustained delivery of NT-3 for potential application in neural regeneration. , 2018, Acta biomaterialia.
[29] Haijun Shen,et al. Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer. , 2017, International journal of pharmaceutics.
[30] Xiaoying Li,et al. Knockout of CTNNB1 by CRISPR-Cas9 technology inhibits cell proliferation through the Wnt/β-catenin signaling pathway , 2018, Biotechnology Letters.
[31] Peng Wang,et al. Genome Editing for Cancer Therapy: Delivery of Cas9 Protein/sgRNA Plasmid via a Gold Nanocluster/Lipid Core–Shell Nanocarrier , 2017, Advanced science.
[32] T. Grossmann,et al. Direct targeting of β-catenin: Inhibition of protein-protein interactions for the inactivation of Wnt signaling. , 2013, Bioorganic & medicinal chemistry.
[33] Hans Clevers,et al. Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.
[34] Xiaoyuan Chen,et al. Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities. , 2018, Biomaterials.
[35] Francisco J. Sánchez-Rivera,et al. Applications of the CRISPR–Cas9 system in cancer biology , 2015, Nature Reviews Cancer.
[36] Yoosoo Yang,et al. Cancer‐derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism‐dependent targeting , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[37] Helmut Blum,et al. Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling , 2014, BMC Genomics.
[38] Dian Yang,et al. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing , 2015, Genes & development.
[39] Hao Wang,et al. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway. , 2014, European journal of pharmacology.
[40] Yi-Wei Lee,et al. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing. , 2017, ACS nano.
[41] Wenjuan Ma,et al. Aptamer-Modified Tetrahedral DNA Nanostructure for Tumor-Targeted Drug Delivery. , 2017, ACS applied materials & interfaces.
[42] R. Zhuo,et al. A Dual-Targeting Delivery System for Effective Genome Editing and In Situ Detecting Related Protein Expression in Edited Cells. , 2018, Biomacromolecules.
[43] J. Doudna,et al. CRISPR-Cas9 Structures and Mechanisms. , 2017, Annual review of biophysics.